FR2696464B1
(fr)
*
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
|
FR2697522B1
(fr)
*
|
1992-10-30 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
FR2698361B1
(fr)
*
|
1992-11-20 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Procédé de préparation d'un acide oxazolidine-1,3 carboxylique-5.
|
IL107950A
(en)
|
1992-12-15 |
2001-04-30 |
Upjohn Co |
b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
|
US5973160A
(en)
*
|
1992-12-23 |
1999-10-26 |
Poss; Michael A. |
Methods for the preparation of novel sidechain-bearing taxanes
|
EP0703909B1
(en)
*
|
1993-06-11 |
2000-04-26 |
PHARMACIA & UPJOHN COMPANY |
Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
|
FR2706457B1
(fr)
*
|
1993-06-16 |
1995-07-28 |
Rhone Poulenc Rorer Sa |
Procédé de préparation d'un acide oxazolidinecarboxylique utile pour préparer des taxoïdes thérapeutiquement actifs.
|
US6005120A
(en)
|
1993-07-20 |
1999-12-21 |
Florida State University |
Tricyclic and tetracyclic taxanes
|
NZ276286A
(en)
*
|
1993-11-12 |
2001-06-29 |
Upjohn Co |
Substituted pyrimidine thio- or oxy-alkyl derivatives and medicaments
|
IL127598A
(en)
*
|
1994-01-28 |
2003-04-10 |
Upjohn Co |
Process for preparing isotaxol analogs
|
US5679807A
(en)
*
|
1995-01-30 |
1997-10-21 |
Hauser, Inc. |
Preparation of taxol and docetaxel through primary amines
|
CA2170661A1
(en)
*
|
1995-03-22 |
1996-09-23 |
John K. Thottathil |
Novel methods for the preparation of taxanes using oaxzolidine intermediates
|
GB9512471D0
(en)
*
|
1995-06-20 |
1995-08-23 |
Pharmacia Spa |
Method for the preparation of taxol and its derivatives
|
US5688977A
(en)
*
|
1996-02-29 |
1997-11-18 |
Napro Biotherapeutics, Inc. |
Method for docetaxel synthesis
|
KR20000010861A
(ko)
*
|
1996-05-08 |
2000-02-25 |
로렌스 티. 마이젠헬더 |
탁솔의 제조 방법
|
US7288665B1
(en)
|
1997-08-18 |
2007-10-30 |
Florida State University |
Process for selective derivatization of taxanes
|
RU2219161C2
(ru)
|
1997-08-21 |
2003-12-20 |
Флорида Стейт Юниверсити |
Способ синтеза таксанов
|
WO1999032109A1
(en)
*
|
1997-12-23 |
1999-07-01 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
EP2266607A3
(en)
|
1999-10-01 |
2011-04-20 |
Immunogen, Inc. |
Immunoconjugates for treating cancer
|
CA2422964A1
(en)
|
2000-09-22 |
2002-03-28 |
Bristol Myers Squibb Company |
Method for reducing toxicity of combined chemotherapies
|
US6891050B2
(en)
*
|
2001-08-10 |
2005-05-10 |
Dabur India Limited |
Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
|
US6881852B2
(en)
*
|
2002-02-05 |
2005-04-19 |
Dabur India Limited |
Process of purification of paclitaxel and docetaxel
|
US7247738B2
(en)
*
|
2002-05-07 |
2007-07-24 |
Dabur India Limited |
Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
|
US6900342B2
(en)
*
|
2002-05-10 |
2005-05-31 |
Dabur India Limited |
Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
WO2004002468A1
(en)
|
2002-06-26 |
2004-01-08 |
Medigene Oncology Gmbh |
Method of producing a cationic liposomal preparation comprising a lipophilic compound
|
EP1562927B1
(en)
*
|
2002-10-09 |
2009-05-13 |
Chatham Biotec Ltd. |
Thio-analogues of paclitaxel and intermediates thereof
|
US6838569B2
(en)
|
2002-12-16 |
2005-01-04 |
Dabur India Limited |
Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
|
WO2005016241A2
(en)
|
2003-05-16 |
2005-02-24 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
US7407973B2
(en)
*
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US7202370B2
(en)
*
|
2003-10-27 |
2007-04-10 |
Conor Medsystems, Inc. |
Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
EP1789074A4
(en)
*
|
2004-08-09 |
2009-08-12 |
Alios Biopharma Inc |
PROTEASE-RESISTANT HYPERGLYCOSYL SYNTHETIC POLYPEPTIDE VARIANTS, ORAL FORMULATIONS AND METHODS OF USING THE SAME
|
US7446126B2
(en)
|
2004-10-08 |
2008-11-04 |
Indena S.P.A. |
Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
|
EP1647552A1
(en)
*
|
2004-10-08 |
2006-04-19 |
INDENA S.p.A. |
Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
|
EP1712552A1
(en)
*
|
2005-04-11 |
2006-10-18 |
INDENA S.p.A. |
Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
|
WO2006089209A2
(en)
*
|
2005-02-17 |
2006-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
WO2007109654A2
(en)
*
|
2006-03-21 |
2007-09-27 |
Dr. Reddy's Laboratories Ltd. |
Docetaxel polymorphs and processes
|
EP3056196A1
(en)
|
2006-03-22 |
2016-08-17 |
SynCore Biotechnology CO., LTD |
Treatment of triple receptor negative breast cancer
|
ITMI20062479A1
(it)
*
|
2006-12-21 |
2008-06-22 |
Indena Spa |
Processo per la preparazione di secotassani
|
WO2008146369A1
(ja)
*
|
2007-05-30 |
2008-12-04 |
Mitsubishi Electric Corporation |
電気車のブレーキ制御装置
|
CA2724550C
(en)
|
2008-05-22 |
2017-01-03 |
Kereos, Inc. |
Combination antitumor therapy
|
KR101003822B1
(ko)
|
2008-06-20 |
2010-12-27 |
주식회사 셀트리온화학연구소 |
도세탁셀의 제조방법 및 도세탁셀의 제조를 위한 신규한중간체
|
US20110172293A1
(en)
|
2008-07-08 |
2011-07-14 |
Fish Jason E |
Methods and Compositions for Modulating Angiogenesis
|
CN101735179B
(zh)
*
|
2008-11-19 |
2012-09-12 |
上海百灵医药科技有限公司 |
一种多烯紫杉醇的制备方法,其中间体及制备方法
|
EP2358693A4
(en)
*
|
2008-11-20 |
2012-04-18 |
Reddys Lab Ltd Dr |
PREPARATION OF DOCETAXEL
|
PL388144A1
(pl)
|
2009-05-29 |
2010-12-06 |
Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością |
Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
|
CN104582717B
(zh)
|
2012-07-19 |
2018-03-13 |
雷德伍德生物科技股份有限公司 |
对cd22有特异性的抗体及其使用方法
|
WO2014074218A1
(en)
|
2012-11-12 |
2014-05-15 |
Redwood Bioscience, Inc. |
Compounds and methods for producing a conjugate
|
CN105142677B
(zh)
|
2013-02-15 |
2019-08-30 |
加利福尼亚大学董事会 |
嵌合抗原受体及其使用方法
|
JP6410790B2
(ja)
|
2013-03-14 |
2018-10-24 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
ミトコンドリアアルデヒドデヒドロゲナーゼ−2調節因子およびその使用方法
|
WO2015081282A1
(en)
|
2013-11-27 |
2015-06-04 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
DK3107899T3
(da)
|
2014-02-19 |
2020-11-16 |
Aviv Therapeutics Inc |
Mitokondriel aldehyddehydrogenase 2 (aldh2)-bindende polycykliske amider og anvendelse deraf til cancerbehandling
|
CN110841074B
(zh)
|
2014-03-21 |
2023-07-18 |
艾伯维公司 |
抗-egfr抗体及抗体药物偶联物
|
US10654875B2
(en)
|
2015-11-12 |
2020-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
EP3231421A1
(en)
|
2016-04-11 |
2017-10-18 |
Greenaltech, S.L. |
Uses of a carotenoid in the treatment or prevention of stress induced conditions
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール.ピー.シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
AU2017299374B2
(en)
|
2016-06-01 |
2021-05-27 |
Servier IP UK Limited |
Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
|
CA3027103A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
JP2019522643A
(ja)
|
2016-06-08 |
2019-08-15 |
アッヴィ・インコーポレイテッド |
抗cd98抗体及び抗体薬物コンジュゲート
|
US20200002421A1
(en)
|
2016-06-08 |
2020-01-02 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
SG10201914119TA
(en)
|
2016-06-08 |
2020-02-27 |
Abbvie Inc |
Anti-b7-h3 antibodies and antibody drug conjugates
|
CA3027033A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
TW201825087A
(zh)
|
2017-01-05 |
2018-07-16 |
杏國新藥股份有限公司 |
胰臟癌治療
|
US20190367621A1
(en)
|
2017-01-18 |
2019-12-05 |
F1 Oncology, Inc. |
Chimeric antigen receptors against axl or ror2 and methods of use thereof
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
CA3090129A1
(en)
|
2018-01-31 |
2019-08-08 |
Galera Labs, Llc |
Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
WO2019200181A1
(en)
|
2018-04-11 |
2019-10-17 |
Ohio State Innovation Foundation |
Methods and compositions for sustained release microparticles for ocular drug delivery
|
EP3823674A4
(en)
|
2018-07-18 |
2022-12-28 |
Manzanita Pharmaceuticals, Inc. |
CONJUGATES FOR DELIVERING AN ANTI-CANCER AGENT TO NERVE CELLS, METHODS OF USE AND METHODS OF PRODUCTION THEREOF
|
AU2020253449A1
(en)
|
2019-04-02 |
2021-11-18 |
Kenjockety Biotechnology, Inc. |
Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
MX2022009355A
(es)
|
2020-01-29 |
2022-09-02 |
Kenjockety Biotechnology Inc |
Anticuerpo anti-mdr1 y uso del mismo.
|
CN116323662A
(zh)
|
2020-06-04 |
2023-06-23 |
肯乔克蒂生物技术股份有限公司 |
抗abcg2抗体及其用途
|
CN116529267A
(zh)
|
2020-06-04 |
2023-08-01 |
肯乔克蒂生物技术股份有限公司 |
Abcg2外排泵-癌症抗原多特异性抗体及其相关组合物、试剂、试剂盒和方法
|
CN116490522A
(zh)
|
2020-09-02 |
2023-07-25 |
肯乔克蒂生物技术股份有限公司 |
抗abcc1抗体及其应用
|
AU2021380659A1
(en)
|
2020-11-13 |
2023-06-01 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
WO2023114658A1
(en)
|
2021-12-13 |
2023-06-22 |
Kenjockety Biotechnology, Inc. |
Anti-abcb1 antibodies
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|